🔎 Trials Near Me

Akèy › Dyabèt › Texas › Houston

Etid klinik pou Dyabèt nan Houston, TX

16 etid pou Dyabèt ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • PlanIt Research, PLLC, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Ap rekriteFaz 1 bonè
  • The University of Texas M. D. Anderson Cancer Center, Houston
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06759701

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3
  • Clinical Research Strategies, Houston
  • DaVita Clinical Research, Houston
  • Aqua Research Institute, Houston
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Ap rekriteFaz 1/2
  • Accurate Clinical Research, Inc, Humble · 17 mi lwen
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Ap rekriteFaz 2
  • Baylor College of Medicine, Houston
Laj 6 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT07224321

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Ap rekriteVolontè an sante akeyi
  • Children's Nutrition Research Center, Houston
Laj 12 a 18 · Tout sèks · Mizajou Jul 7, 2026 · NCT06959901

CGM for Management of Type 2 Diabetes in Pregnancy

Ap rekrite
  • University of Texas Health Science Center at Houston, Houston
Laj 18 a 50 · Fanm · Mizajou Jun 29, 2026 · NCT06628453

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

Ap rekriteFaz 2
  • Baylor College of Medicine (BCM), Houston
  • The University of Texas Health Science Center at Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT05650229

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Ap rekriteFaz 4
  • University of Texas Health Science Center, Houston
Laj 18 ak plis · Fanm · Mizajou Jun 25, 2026 · NCT06445946

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Ap rekrite
  • Aqua Research Institute Llc, Houston
Laj 18 a 84 · Tout sèks · Mizajou Apr 13, 2026 · NCT06190717

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Ap rekriteEtid obsèvasyon
  • Baylor College of Medicine, Houston
Laj 12 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT06837181

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Baylor College of Medicine, Houston
Tout laj · Tout sèks · Mizajou Feb 4, 2026 · NCT01694940

Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

Ap rekriteFaz 4
  • Axsendo Clinical Research, Houston
Laj 45 a 85 · Tout sèks · Mizajou Jan 8, 2026 · NCT07326553

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Ap rekriteFaz 3
  • Mt. Olympus Medical Research, Houston
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05930210

Rare and Atypical Diabetes Network

Ap rekriteEtid obsèvasyon
  • Baylor College of Medicine, Houston
Tout laj · Tout sèks · Mizajou Aug 14, 2025 · NCT05544266

Etid Dyabèt nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.